COUCHBASE INC (BASE)

US22207T1016 - Common Stock

16  +0.17 (+1.07%)

After market: 16 0 (0%)

Fundamental Rating

4

Taking everything into account, BASE scores 4 out of 10 in our fundamental rating. BASE was compared to 83 industry peers in the IT Services industry. BASE has a great financial health rating, but its profitability evaluates not so good. BASE is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

BASE had negative earnings in the past year.
BASE had a negative operating cash flow in the past year.
In the past 5 years BASE always reported negative net income.
BASE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of BASE (-36.16%) is worse than 86.42% of its industry peers.
The Return On Equity of BASE (-63.45%) is worse than 75.31% of its industry peers.
Industry RankSector Rank
ROA -36.16%
ROE -63.45%
ROIC N/A
ROA(3y)-27.17%
ROA(5y)-32.49%
ROE(3y)-46.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 88.35%, BASE belongs to the best of the industry, outperforming 98.77% of the companies in the same industry.
BASE's Gross Margin has been stable in the last couple of years.
BASE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

BASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BASE has more shares outstanding
There is no outstanding debt for BASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BASE has an Altman-Z score of 2.08. This is not the best score and indicates that BASE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.08, BASE perfoms like the industry average, outperforming 43.21% of the companies in the same industry.
There is no outstanding debt for BASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.08
ROIC/WACCN/A
WACC11.51%

2.3 Liquidity

BASE has a Current Ratio of 2.13. This indicates that BASE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, BASE is in the better half of the industry, outperforming 67.90% of the companies in the same industry.
BASE has a Quick Ratio of 2.13. This indicates that BASE is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.13, BASE is doing good in the industry, outperforming 69.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13

6

3. Growth

3.1 Past

BASE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.43%, which is quite impressive.
BASE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.27%.
The Revenue has been growing by 20.34% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)61.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)19.27%
Revenue growth 3Y20.34%
Revenue growth 5YN/A
Sales Q2Q%12.7%

3.2 Future

Based on estimates for the next years, BASE will show a very strong growth in Earnings Per Share. The EPS will grow by 29.02% on average per year.
The Revenue is expected to grow by 19.59% on average over the next years. This is quite good.
EPS Next Y49.54%
EPS Next 2Y32.69%
EPS Next 3Y29.02%
EPS Next 5YN/A
Revenue Next Year17.7%
Revenue Next 2Y15.84%
Revenue Next 3Y15.8%
Revenue Next 5Y19.59%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BASE. In the last year negative earnings were reported.
Also next year BASE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BASE's earnings are expected to grow with 29.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.69%
EPS Next 3Y29.02%

0

5. Dividend

5.1 Amount

No dividends for BASE!.
Industry RankSector Rank
Dividend Yield N/A

COUCHBASE INC

NASDAQ:BASE (1/8/2025, 8:00:00 PM)

After market: 16 0 (0%)

16

+0.17 (+1.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-03 2024-12-03/amc
Earnings (Next)N/A N/A
Inst Owners87.11%
Inst Owner Change0%
Ins Owners1.16%
Ins Owner Change-1.8%
Market Cap837.60M
Analysts82.73
Price Target23.66 (47.88%)
Short Float %2.83%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.67%
Min EPS beat(2)32.33%
Max EPS beat(2)39%
EPS beat(4)4
Avg EPS beat(4)40.86%
Min EPS beat(4)32.33%
Max EPS beat(4)59.28%
EPS beat(8)8
Avg EPS beat(8)38.72%
EPS beat(12)12
Avg EPS beat(12)34.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)-0.32%
Revenue beat(4)2
Avg Revenue beat(4)1.85%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)5.25%
Revenue beat(8)6
Avg Revenue beat(8)2.62%
Revenue beat(12)10
Avg Revenue beat(12)3.23%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.98%
PT rev (3m)0.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.17%
EPS NY rev (1m)13.59%
EPS NY rev (3m)21.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.09
P/FCF N/A
P/OCF N/A
P/B 6.61
P/tB 6.61
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS3.91
BVpS2.42
TBVpS2.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.16%
ROE -63.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.35%
FCFM N/A
ROA(3y)-27.17%
ROA(5y)-32.49%
ROE(3y)-46.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5YN/A
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 205.76%
Cap/Sales 1.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z 2.08
F-Score4
WACC11.51%
ROIC/WACCN/A
Cap/Depr(3y)133.87%
Cap/Depr(5y)241.06%
Cap/Sales(3y)2.31%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
EPS Next Y49.54%
EPS Next 2Y32.69%
EPS Next 3Y29.02%
EPS Next 5YN/A
Revenue 1Y (TTM)19.27%
Revenue growth 3Y20.34%
Revenue growth 5YN/A
Sales Q2Q%12.7%
Revenue Next Year17.7%
Revenue Next 2Y15.84%
Revenue Next 3Y15.8%
Revenue Next 5Y19.59%
EBIT growth 1Y-1.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.36%
EBIT Next 3Y28.26%
EBIT Next 5YN/A
FCF growth 1Y18.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.8%
OCF growth 3YN/A
OCF growth 5YN/A